FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

AstraZeneca Plc to increase Dividend by 7% for 2024

AstraZeneca plc (LON:AZN) announces a 7% increase in annual dividend for 2024 to $3.10 per share, reflecting confidence in performance and cash generation...

Tesco plc Preliminary Results show Market Share Gains and Positive Volume Growth

Tesco plc (LON:TSCO) announces Preliminary Results 2023/24, showing market share gains & positive volume growth as customers shop more. CEO Ken Murphy highlights exceptional performance & strong financial results with..

HSBC sells Argentina business to Grupo Financiero Galicia for US$550m

HSBC Latin America B.V. to sell its business in Argentina to Grupo Financiero Galicia for US$550m. Noel Quinn calls it a strategic move for the bank...

Imperial Brands on track to meet half-year and full-year guidance

Imperial Brands PLC (LON:IMB) pre-close trading update shows strong tobacco pricing and NGP growth, meeting full-year expectations with improved cash conversion...

Aviva Plc completes acquisition of AIG Life UK

Aviva plc completes £453m acquisition of AIG Life UK from AIG. Learn more about this British insurance giant with 18 million customers...

AstraZeneca Plc’s Enhertu approved in the US for HER2+ solid tumours

AstraZeneca plc and Daiichi Sankyo's Enhertu has gained US approval for treating HER2-positive solid tumours, marking a significant advancement in cancer treatment...

Rio Tinto Plc appoints Bold Baatar as Chief Commercial Officer

Rio Tinto plc appoints Bold Baatar as Chief Commercial Officer to lead global business development. Bold will succeed Alf Barrios in the role...

Melrose Industries PLC -3.6% potential downside indicated by Numis

Melrose Industries PLC with ticker (LON:MRO) now has a potential downside of -3.6% according to Numis.Numis set a target price of 640 GBX for the company, which when compared to..

Diploma PLC 24.2% potential upside indicated by Berenberg Bank

Diploma PLC with ticker (LON:DPLM) now has a potential upside of 24.2% according to Berenberg Bank.Berenberg Bank set a target price of 4,400 GBX for the company, which when compared..

Rentokil Initial plc 29.0% potential upside indicated by RBC Capital Markets

Rentokil Initial plc with ticker (LON:RTO) now has a potential upside of 29.0% according to RBC Capital Markets.RBC Capital Markets set a target price of 590 GBX for the company,..

Relx PLC 6.8% potential upside indicated by Berenberg Bank

Relx PLC with ticker (LON:REL) now has a potential upside of 6.8% according to Berenberg Bank.Berenberg Bank set a target price of 3,500 GBX for the company, which when compared..

Ashtead Group plc -9.6% potential downside indicated by RBC Capital Markets

Ashtead Group plc with ticker (LON:AHT) now has a potential downside of -9.6% according to RBC Capital Markets.RBC Capital Markets set a target price of 5,100 GBX for the company,..

International Consolidated Airlns Grp SA 27.1% potential upside indicated by RBC Capital Markets

International Consolidated Airlns Grp SA with ticker (LON:IAG) now has a potential upside of 27.1% according to RBC Capital Markets.RBC Capital Markets set a target price of 220 GBX for..

Entain PLC 45.9% potential upside indicated by Berenberg Bank

Entain PLC with ticker (LON:ENT) now has a potential upside of 45.9% according to Berenberg Bank.Berenberg Bank set a target price of 1,140 GBX for the company, which when compared..

AstraZeneca’s Imfinzi shows positive results in Phase III trial for small cell lung cancer

AstraZeneca's Imfinzi shows significant improvement in overall survival and progression-free survival in limited-stage small cell lung cancer patients after chemoradiotherapy. Exciting breakthrough in treatment...

Entain plc Chairman Barry Gibson to retire, Stella David to succeed

Entain plc announces Barry Gibson's retirement as Chair, with Stella David set to take over. Stella, current interim CEO, brings extensive experience to the role...

LondonMetric Property Additional Listing in Relation to Dividend

LondonMetric Property Plc (LON:LMP) announces third quarterly dividend. Find out more about the dividend scheme and upcoming Admission details...

HSBC Holdings completes sale of HSBC Bank Canada to RBC

HSBC Holdings plc (LON:HSBA) completes sale of HSBC Bank Canada to RBC, unlocking value and planning special dividend for shareholders in 2024...

AstraZeneca’s Voydeya approved in the US as add-on therapy for PNH patients with EVH

AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment...

Marathon Oil Corporation – Consensus ‘buy’ rating and 15.7% Upside Potential

Marathon Oil Corporation which can be found using ticker (MRO) have now 21 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range..

Search

Funds

FTSE 100

AstraZeneca Plc to increase Dividend by 7% for 2024

AstraZeneca plc (LON:AZN) announces a 7% increase in annual dividend for 2024 to $3.10 per share, reflecting confidence in performance and cash generation...

Tesco plc Preliminary Results show Market Share Gains and Positive Volume Growth

Tesco plc (LON:TSCO) announces Preliminary Results 2023/24, showing market share gains & positive volume growth as customers shop more. CEO Ken Murphy highlights exceptional performance & strong financial results with sales growth, cost savings, and customer-focused strategies...

HSBC sells Argentina business to Grupo Financiero Galicia for US$550m

HSBC Latin America B.V. to sell its business in Argentina to Grupo Financiero Galicia for US$550m. Noel Quinn calls it a strategic move for the bank...

Imperial Brands on track to meet half-year and full-year guidance

Imperial Brands PLC (LON:IMB) pre-close trading update shows strong tobacco pricing and NGP growth, meeting full-year expectations with improved cash conversion...

Aviva Plc completes acquisition of AIG Life UK

Aviva plc completes £453m acquisition of AIG Life UK from AIG. Learn more about this British insurance giant with 18 million customers...

AstraZeneca Plc’s Enhertu approved in the US for HER2+ solid tumours

AstraZeneca plc and Daiichi Sankyo's Enhertu has gained US approval for treating HER2-positive solid tumours, marking a significant advancement in cancer treatment...

Rio Tinto Plc appoints Bold Baatar as Chief Commercial Officer

Rio Tinto plc appoints Bold Baatar as Chief Commercial Officer to lead global business development. Bold will succeed Alf Barrios in the role...

AstraZeneca’s Imfinzi shows positive results in Phase III trial for small cell lung cancer

AstraZeneca's Imfinzi shows significant improvement in overall survival and progression-free survival in limited-stage small cell lung cancer patients after chemoradiotherapy. Exciting breakthrough in treatment...

Entain plc Chairman Barry Gibson to retire, Stella David to succeed

Entain plc announces Barry Gibson's retirement as Chair, with Stella David set to take over. Stella, current interim CEO, brings extensive experience to the role...

LondonMetric Property Additional Listing in Relation to Dividend

LondonMetric Property Plc (LON:LMP) announces third quarterly dividend. Find out more about the dividend scheme and upcoming Admission details...

HSBC Holdings completes sale of HSBC Bank Canada to RBC

HSBC Holdings plc (LON:HSBA) completes sale of HSBC Bank Canada to RBC, unlocking value and planning special dividend for shareholders in 2024...

AstraZeneca’s Voydeya approved in the US as add-on therapy for PNH patients with EVH

AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment...
Search

Funds

FTSE 100

FTSE 100

Funds